diss_wolf_theresa.pdf (2449 KB) - Ernst-Moritz-Arndt-Universität ...

146 Literatur
and Adults (vol. 1), pp.3-29. Lawrence Erlbaum Associates, Publishers, Hillsdale,
New Jersey
Graham, F.K. (1997). Afterword: preattentive processing and passive and active attention. In
Lang, P.J., Somins, R.F. & Balaban, M.T. (Eds.) Attention and Orienting: Sensory
and Motivational Processes. pp 417-452 Lawrence Erlbaum Association, Inc Publishers,
Mahwah: New Jersey
Grillon, C., Ameli, R., Charney, D.S., Krystal, J. & Braff, D.L. (1992). Startle gating deficits
occur across prepulse intensities in schizophrenic patients. Biological Psychiatry,
32(10), 939-943
Grunwald, T., Boutros, N.N., Pezer, N., von Oertzen, J., Fernández, G., Schaller, C. & Elger,
C.E. (2003). Neuronal substrates of sensory gating within the human brain. Biological
Psychiatry, 53, 511-519
Gur, R.E., Kohler, C., Ragland, J.D., Siegel, S.J., Bilker, W.B., Loughead, J., Phend, N.,
Gur, R.C. (2003). Neurocognitive performance and clinical changes in olanzapinetreated
patients with schizophrenia. Neuropsychopharmacology, 28(11), 2029-2036
Hackley, S.A. & Graham, F.K. (1987). Effects of attending selectively to the spatial position
of reflex-eliciting and reflex-modulating stimuli. Journal of expermental psychology:
human perception and performance, 13(3), 411-424
Häfner, H., Löffler, W., Maurer, K., Riecher-Rössler, A. & Stein, A. (1999). IRAOS - Interview
für die retrospektive Erfassung des Krankheitsbeginns und -verlaufs bei Schizophrenie
und anderen Psychosen. Verlag: Hans Huber
Häfner, H. (2003). Gender differences in schizophrenia. Psychoneuroendocrinology, 28, 17-
54
Hamm, A.O., Weike, A.I. & Schupp, H.T. (2001). The effect of neuroleptic medication on
prepulse inhibition in schizophrenia patients: current status and future issues. Psychopharmacology,
156(2-3), 259-265
Hammer, T.B., Oranje, B., Fagerlund, B., Bro, H. & Glenthøj, B.Y. (2011). Stability of prepulse
inhibition and habituation of the startle reflex in schizophrenia: a 6-year follow-up
study of initially antipsychotic-naive, first-episode schizophrenia patients.
International journal of neuropsychopharmacology, 14(7), 913-925